Dr. Mitesh Kapadia, MD, PhD Launches Eyelid Skin Cancer Awareness Campaign

Wellesley, MA -- (SBWIRE) -- 10/02/2014 -- Eyelid cancer accounts for approximately five to ten percent of skin cancers and 90 percent of patients diagnosed with this type of skin cancer find theirs is of the basal cell carcinoma type. When detected and treated early, patients find this type of cancer is typically curable, yet the significant risk of damage to nearby ocular structures remains of concern. Some patients find the cancer leads to blindness, when the tumor isn't removed in a timely manner. For this reason, individuals need to ensure they seek treatment when a scar-like texture or appearance develops on an eyelid or a tumor begins to develop.